MAB8051

antibody from R&D Systems

Targeting: TNFRSF11B OCIF, OPG, TR1

ELISA (Recommended by provider)

Antibody Data

Product number

MAB8051

Provider

R&D Systems

Product name

Anti-Human Osteoprotegerin/TNFRSF11B Monoclonal Antibody (Clone 69127)

Antibody type

Monoclonal

Antigen

S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Osteoprotegerin/TNFRSF11B, Glu22-Leu401

Description

Protein A or G purified from ascites

Reactivity

Human

Host

Mouse

Antigen sequence

O00300


Isotype

IgG

Vial size

500 µg

References

Submitted references

Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.

Giovannini S, Tinelli G, Biscetti F, Straface G, Angelini F, Pitocco D, Mucci L, Landolfi R, Flex A
Cardiovascular diabetology 2017 Aug 8;16(1):99

---

Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine.

Hu H, Kwun J, Aizenstein BD, Knechtle SJ
Transplantation 2009 Jun 27;87(12):1814-20

---

The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA.

Harding G, Mak YT, Evans B, Cheung J, MacDonald D, Hampson G
Cytokine 2006 Oct;36(1-2):57-68

---

Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?

Cross SS, Yang Z, Brown NJ, Balasubramanian SP, Evans CA, Woodward JK, Neville-Webbe HL, Lippitt JM, Reed MW, Coleman RE, Holen I
International journal of cancer 2006 Apr 15;118(8):1901-8

---

Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.

Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT
The Journal of rheumatology 2005 Apr;32(4):713-20